Six speakers will offer a combination of TED-style short talks and fireside chats about their entrepreneurial journeys.
Weill Cornell Medicine and Cornell Engineering are launching an initiative, led by Emmanuel Giannelis, to form cross-disciplinary partnerships.
The 14th episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features David Stein MBA ‘20, co-founder and CEO of Ash Wellness.
The blood stem cell mutation, known as DNMT3A R882, leads to the growth of a large population of circulating blood cells that also contain this mutation.
A new book by Cornell authors traces how an influx of New Englanders made an indelible mark on Brooklyn, and how the arrival of Catholic and Jewish immigrants challenged that hegemony.
Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.
New findings could lead to the development of treatments aimed at ameliorating the metabolic effects of the disease.
Cornell Tech researchers have developed a mechanism for preserving anonymity in encrypted messaging – which conceals message content but might not cloak the sender’s identity – while simultaneously blocking unwanted or abusive messages.
This is the largest federal grant ever awarded to Weill Cornell Medicine and the fourth consecutive time this initiative has been funded by the NIH, representing 20 years of continuous funding.